Literature DB >> 23507145

Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.

Heng Du1, Lan Guo1, Xiaoping Wu2, Alexander A Sosunov2, Guy M McKhann2, John Xi Chen3, Shirley ShiDu Yan4.   

Abstract

The coexistence of neuronal mitochondrial pathology and synaptic dysfunction is an early pathological feature of Alzheimer's disease (AD). Cyclophilin D (CypD), an integral part of mitochondrial permeability transition pore (mPTP), is involved in amyloid beta (Aβ)-instigated mitochondrial dysfunction. Blockade of CypD prevents Aβ-induced mitochondrial malfunction and the consequent cognitive impairments. Here, we showed the elimination of reactive oxygen species (ROS) by antioxidants probucol or superoxide dismutase (SOD)/catalase blocks Aβ-mediated inactivation of protein kinase A (PKA)/cAMP regulatory-element-binding (CREB) signal transduction pathway and loss of synapse, suggesting the detrimental effects of oxidative stress on neuronal PKA/CREB activity. Notably, neurons lacking CypD significantly attenuate Aβ-induced ROS. Consequently, CypD-deficient neurons are resistant to Aβ-disrupted PKA/CREB signaling by increased PKA activity, phosphorylation of PKA catalytic subunit (PKA C), and CREB. In parallel, lack of CypD protects neurons from Aβ-induced loss of synapses and synaptic dysfunction. Furthermore, compared to the mAPP mice, CypD-deficient mAPP mice reveal less inactivation of PKA-CREB activity and increased synaptic density, attenuate abnormalities in dendritic spine maturation, and improve spontaneous synaptic activity. These findings provide new insights into a mechanism in the crosstalk between the CypD-dependent mitochondrial oxidative stress and signaling cascade, leading to synaptic injury, functioning through the PKA/CREB signal transduction pathway.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid beta; Mitochondrial permeability transition; Oxidative stress; PKA/CREB signaling; Synaptic alteration

Mesh:

Substances:

Year:  2013        PMID: 23507145      PMCID: PMC3868643          DOI: 10.1016/j.bbadis.2013.03.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  60 in total

Review 1.  The role of reactive oxygen species in mitochondrial permeability transition.

Authors:  A E Vercesi; A J Kowaltowski; M T Grijalba; A R Meinicke; R F Castilho
Journal:  Biosci Rep       Date:  1997-02       Impact factor: 3.840

2.  Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42.

Authors:  Peter J Crouch; Rachel Blake; James A Duce; Giuseppe D Ciccotosto; Qiao-Xin Li; Kevin J Barnham; Cyril C Curtain; Robert A Cherny; Roberto Cappai; Thomas Dyrks; Colin L Masters; Ian A Trounce
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

3.  Basal versus apical dendritic long-term potentiation of commissural afferents to hippocampal CA1: a current-source density study.

Authors:  T Kaibara; L S Leung
Journal:  J Neurosci       Date:  1993-06       Impact factor: 6.167

4.  The participation of reactive oxygen species and protein thiols in the mechanism of mitochondrial inner membrane permeabilization by calcium plus prooxidants.

Authors:  V G Valle; M M Fagian; L S Parentoni; A R Meinicke; A E Vercesi
Journal:  Arch Biochem Biophys       Date:  1993-11-15       Impact factor: 4.013

5.  RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

Authors:  S D Yan; X Chen; J Fu; M Chen; H Zhu; A Roher; T Slattery; L Zhao; M Nagashima; J Morser; A Migheli; P Nawroth; D Stern; A M Schmidt
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

6.  Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification.

Authors:  Kenneth M Humphries; Michael S Deal; Susan S Taylor
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

7.  Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

Authors:  B J Cummings; C J Pike; R Shankle; C W Cotman
Journal:  Neurobiol Aging       Date:  1996 Nov-Dec       Impact factor: 4.673

8.  Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

Authors:  S D Yan; A M Schmidt; G M Anderson; J Zhang; J Brett; Y S Zou; D Pinsky; D Stern
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

9.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Authors:  K Hensley; J M Carney; M P Mattson; M Aksenova; M Harris; J F Wu; R A Floyd; D A Butterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.

Authors:  Lan Guo; Heng Du; Shiqiang Yan; Xiaoping Wu; Guy M McKhann; John Xi Chen; Shirley ShiDu Yan
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more
  40 in total

1.  How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  J Autoimmun       Date:  2013-08-17       Impact factor: 7.094

Review 2.  Clioquinol: To harm or heal.

Authors:  Dominique R Perez; Larry A Sklar; Alexandre Chigaev
Journal:  Pharmacol Ther       Date:  2019-03-18       Impact factor: 12.310

3.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction.

Authors:  Xueqi Gan; Long Wu; Shengbin Huang; Changjia Zhong; Honglian Shi; Guangyue Li; Haiyang Yu; Russell Howard Swerdlow; John Xi Chen; Shirley ShiDu Yan
Journal:  Free Radic Biol Med       Date:  2014-07-23       Impact factor: 7.376

5.  Identification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aβ-Mediated Mitochondrial Dysfunction.

Authors:  Koteswara Rao Valasani; Qinru Sun; Du Fang; Zhihua Zhang; Qing Yu; Yaopeng Guo; Jianping Li; Anuradha Roy; Shirley ShiDu Yan
Journal:  ACS Med Chem Lett       Date:  2016-01-06       Impact factor: 4.345

Review 6.  The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.

Authors:  Laura J Blair; Jeremy D Baker; Jonathan J Sabbagh; Chad A Dickey
Journal:  J Neurochem       Date:  2015-02-24       Impact factor: 5.372

Review 7.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 8.  A Mitocentric View of Alzheimer's Disease.

Authors:  Hao Hu; Chen-Chen Tan; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-10-01       Impact factor: 5.590

9.  Cyclophilin D regulates neuronal activity-induced filopodiagenesis by fine-tuning dendritic mitochondrial calcium dynamics.

Authors:  Shaomei Sui; Jing Tian; Esha Gauba; Qi Wang; Lan Guo; Heng Du
Journal:  J Neurochem       Date:  2018-08-16       Impact factor: 5.372

10.  Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Du Fang; Russell Howard Swerdlow; Haiyang Yu; John Xi Chen; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.